ID MIPEP_HUMAN Reviewed; 713 AA. AC Q99797; Q5JV15; Q5T9Q9; Q96G65; DT 15-JUL-1999, integrated into UniProtKB/Swiss-Prot. DT 26-FEB-2008, sequence version 2. DT 24-JAN-2024, entry version 192. DE RecName: Full=Mitochondrial intermediate peptidase; DE Short=MIP; DE EC=3.4.24.59; DE Flags: Precursor; GN Name=MIPEP; Synonyms=MIP; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT GLY-488. RC TISSUE=Liver; RX PubMed=9073519; DOI=10.1006/geno.1996.4586; RA Chew A., Buck E.A., Peretz S., Sirugo G., Rinaldo P., Isaya G.; RT "Cloning, expression, and chromosomal assignment of the human mitochondrial RT intermediate peptidase gene (MIPEP)."; RL Genomics 40:493-496(1997). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLY-488. RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15057823; DOI=10.1038/nature02379; RA Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L., RA Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S., RA Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P., RA Ambrose K.D., Andrews D.T., Ashwell R.I.S., Babbage A.K., Bagguley C.L., RA Bailey J., Bannerjee R., Barlow K.F., Bates K., Beasley H., Bird C.P., RA Bray-Allen S., Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P., RA Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M., Clegg S.C., RA Cobley V., Collins J.E., Corby N., Coville G.J., Deloukas P., Dhami P., RA Dunham I., Dunn M., Earthrowl M.E., Ellington A.G., Faulkner L., RA Frankish A.G., Frankland J., French L., Garner P., Garnett J., RA Gilbert J.G.R., Gilson C.J., Ghori J., Grafham D.V., Gribble S.M., RA Griffiths C., Hall R.E., Hammond S., Harley J.L., Hart E.A., Heath P.D., RA Howden P.J., Huckle E.J., Hunt P.J., Hunt A.R., Johnson C., Johnson D., RA Kay M., Kimberley A.M., King A., Laird G.K., Langford C.J., Lawlor S., RA Leongamornlert D.A., Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., RA Martin S., Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S., RA Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I., Pelan S., RA Phillimore B., Porter K.M., Rice C.M., Searle S., Sehra H.K., Shownkeen R., RA Skuce C.D., Smith M., Steward C.A., Sycamore N., Tester J., Thomas D.W., RA Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P., RA Whitehead S.L., Willey D.L., Wilming L., Wray P.W., Wright M.W., Young L., RA Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Beck S., Bentley D.R., RA Rogers J., Ross M.T.; RT "The DNA sequence and analysis of human chromosome 13."; RL Nature 428:522-528(2004). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLY-488. RC TISSUE=Uterus; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [5] RP ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-126, AND IDENTIFICATION BY MASS RP SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=19608861; DOI=10.1126/science.1175371; RA Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., RA Olsen J.V., Mann M.; RT "Lysine acetylation targets protein complexes and co-regulates major RT cellular functions."; RL Science 325:834-840(2009). RN [6] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21269460; DOI=10.1186/1752-0509-5-17; RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., RA Bennett K.L., Superti-Furga G., Colinge J.; RT "Initial characterization of the human central proteome."; RL BMC Syst. Biol. 5:17-17(2011). RN [7] RP INVOLVEMENT IN COXPD31, AND VARIANTS COXPD31 GLN-71; PHE-306; GLU-343; RP ASP-512 AND ARG-582. RX PubMed=27799064; DOI=10.1186/s13073-016-0360-6; RA Eldomery M.K., Akdemir Z.C., Voegtle F.N., Charng W.L., Mulica P., RA Rosenfeld J.A., Gambin T., Gu S., Burrage L.C., Al Shamsi A., Penney S., RA Jhangiani S.N., Zimmerman H.H., Muzny D.M., Wang X., Tang J., Medikonda R., RA Ramachandran P.V., Wong L.J., Boerwinkle E., Gibbs R.A., Eng C.M., RA Lalani S.R., Hertecant J., Rodenburg R.J., Abdul-Rahman O.A., Yang Y., RA Xia F., Wang M.C., Lupski J.R., Meisinger C., Sutton V.R.; RT "MIPEP recessive variants cause a syndrome of left ventricular non- RT compaction, hypotonia, and infantile death."; RL Genome Med. 8:106-106(2016). CC -!- FUNCTION: Cleaves proteins, imported into the mitochondrion, to their CC mature size. CC -!- CATALYTIC ACTIVITY: CC Reaction=Release of an N-terminal octapeptide as second stage of CC processing of some proteins imported into the mitochondrion.; CC EC=3.4.24.59; CC -!- COFACTOR: CC Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250}; CC Note=Binds 1 zinc ion. {ECO:0000250}; CC -!- ACTIVITY REGULATION: Activity is divalent cation-dependent. It is CC stimulated by manganese, magnesium or calcium ions and reversibly CC inhibited by zinc, cobalt and iron (By similarity). {ECO:0000250}. CC -!- SUBUNIT: Monomer. {ECO:0000250}. CC -!- SUBCELLULAR LOCATION: Mitochondrion matrix. CC -!- DISEASE: Combined oxidative phosphorylation deficiency 31 (COXPD31) CC [MIM:617228]: An autosomal recessive, severe mitochondrial disease with CC multisystemic manifestations appearing soon after birth or in early CC infancy. Clinical features include left ventricular non-compaction, CC global developmental delay, severe hypotonia, seizures, cataract, and CC abnormal movements. Death may occur in early childhood. CC {ECO:0000269|PubMed:27799064}. Note=The disease is caused by variants CC affecting the gene represented in this entry. CC -!- SIMILARITY: Belongs to the peptidase M3 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; U80034; AAC51231.1; -; mRNA. DR EMBL; AK291923; BAF84612.1; -; mRNA. DR EMBL; AL157368; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AL139080; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AL445985; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC009934; AAH09934.1; -; mRNA. DR CCDS; CCDS9303.1; -. DR RefSeq; NP_005923.2; NM_005932.3. DR AlphaFoldDB; Q99797; -. DR SMR; Q99797; -. DR BioGRID; 110431; 101. DR IntAct; Q99797; 32. DR MINT; Q99797; -. DR STRING; 9606.ENSP00000371607; -. DR MEROPS; M03.006; -. DR iPTMnet; Q99797; -. DR MetOSite; Q99797; -. DR PhosphoSitePlus; Q99797; -. DR SwissPalm; Q99797; -. DR BioMuta; MIPEP; -. DR DMDM; 182639267; -. DR EPD; Q99797; -. DR jPOST; Q99797; -. DR MassIVE; Q99797; -. DR MaxQB; Q99797; -. DR PaxDb; 9606-ENSP00000371607; -. DR PeptideAtlas; Q99797; -. DR ProteomicsDB; 78477; -. DR Pumba; Q99797; -. DR Antibodypedia; 22428; 455 antibodies from 28 providers. DR DNASU; 4285; -. DR Ensembl; ENST00000382172.4; ENSP00000371607.3; ENSG00000027001.10. DR GeneID; 4285; -. DR KEGG; hsa:4285; -. DR MANE-Select; ENST00000382172.4; ENSP00000371607.3; NM_005932.4; NP_005923.3. DR UCSC; uc001uox.5; human. DR AGR; HGNC:7104; -. DR CTD; 4285; -. DR DisGeNET; 4285; -. DR GeneCards; MIPEP; -. DR HGNC; HGNC:7104; MIPEP. DR HPA; ENSG00000027001; Low tissue specificity. DR MalaCards; MIPEP; -. DR MIM; 602241; gene. DR MIM; 617228; phenotype. DR neXtProt; NX_Q99797; -. DR OpenTargets; ENSG00000027001; -. DR Orphanet; 478049; Lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome. DR PharmGKB; PA30822; -. DR VEuPathDB; HostDB:ENSG00000027001; -. DR eggNOG; KOG2090; Eukaryota. DR GeneTree; ENSGT00950000183171; -. DR HOGENOM; CLU_001805_0_2_1; -. DR InParanoid; Q99797; -. DR OMA; ALMFEYM; -. DR OrthoDB; 735202at2759; -. DR PhylomeDB; Q99797; -. DR TreeFam; TF105715; -. DR PathwayCommons; Q99797; -. DR SignaLink; Q99797; -. DR BioGRID-ORCS; 4285; 275 hits in 1159 CRISPR screens. DR ChiTaRS; MIPEP; human. DR GenomeRNAi; 4285; -. DR Pharos; Q99797; Tbio. DR PRO; PR:Q99797; -. DR Proteomes; UP000005640; Chromosome 13. DR RNAct; Q99797; Protein. DR Bgee; ENSG00000027001; Expressed in right atrium auricular region and 162 other cell types or tissues. DR GO; GO:0005759; C:mitochondrial matrix; IEA:UniProtKB-SubCell. DR GO; GO:0005739; C:mitochondrion; IDA:HPA. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0004222; F:metalloendopeptidase activity; IBA:GO_Central. DR GO; GO:0006518; P:peptide metabolic process; IBA:GO_Central. DR GO; GO:0006627; P:protein processing involved in protein targeting to mitochondrion; IBA:GO_Central. DR CDD; cd06457; M3A_MIP; 1. DR Gene3D; 1.10.1370.40; -; 1. DR Gene3D; 3.40.390.10; Collagenase (Catalytic Domain); 1. DR Gene3D; 1.10.1370.10; Neurolysin, domain 3; 1. DR InterPro; IPR033851; M3A_MIP. DR InterPro; IPR024079; MetalloPept_cat_dom_sf. DR InterPro; IPR024077; Neurolysin/TOP_dom2. DR InterPro; IPR045090; Pept_M3A_M3B. DR InterPro; IPR001567; Pept_M3A_M3B_dom. DR PANTHER; PTHR11804:SF79; MITOCHONDRIAL INTERMEDIATE PEPTIDASE; 1. DR PANTHER; PTHR11804; PROTEASE M3 THIMET OLIGOPEPTIDASE-RELATED; 1. DR Pfam; PF01432; Peptidase_M3; 1. DR SUPFAM; SSF55486; Metalloproteases ('zincins'), catalytic domain; 1. DR PROSITE; PS00142; ZINC_PROTEASE; 1. DR Genevisible; Q99797; HS. PE 1: Evidence at protein level; KW Acetylation; Calcium; Cobalt; Disease variant; Hydrolase; Iron; Magnesium; KW Manganese; Metal-binding; Metalloprotease; Mitochondrion; KW Primary mitochondrial disease; Protease; Reference proteome; KW Transit peptide; Zinc. FT TRANSIT 1..35 FT /note="Mitochondrion" FT CHAIN 36..713 FT /note="Mitochondrial intermediate peptidase" FT /id="PRO_0000028579" FT ACT_SITE 496 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10095" FT BINDING 495 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_note="catalytic" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10095" FT BINDING 499 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_note="catalytic" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10095" FT BINDING 502 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_note="catalytic" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10095" FT MOD_RES 126 FT /note="N6-acetyllysine" FT /evidence="ECO:0007744|PubMed:19608861" FT VARIANT 71 FT /note="L -> Q (in COXPD31; dbSNP:rs1057518740)" FT /evidence="ECO:0000269|PubMed:27799064" FT /id="VAR_078009" FT VARIANT 137 FT /note="A -> V (in dbSNP:rs2312296)" FT /id="VAR_038934" FT VARIANT 306 FT /note="L -> F (in COXPD31; dbSNP:rs143912947)" FT /evidence="ECO:0000269|PubMed:27799064" FT /id="VAR_078010" FT VARIANT 340 FT /note="R -> Q (in dbSNP:rs11551114)" FT /id="VAR_038935" FT VARIANT 343 FT /note="K -> E (in COXPD31; dbSNP:rs1057518741)" FT /evidence="ECO:0000269|PubMed:27799064" FT /id="VAR_078011" FT VARIANT 453 FT /note="R -> H (in dbSNP:rs12858248)" FT /id="VAR_038936" FT VARIANT 488 FT /note="S -> G (in dbSNP:rs7333040)" FT /evidence="ECO:0000269|PubMed:14702039, FT ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:9073519" FT /id="VAR_038937" FT VARIANT 512 FT /note="H -> D (in COXPD31; uncertain significance; FT dbSNP:rs779598020)" FT /evidence="ECO:0000269|PubMed:27799064" FT /id="VAR_078012" FT VARIANT 582 FT /note="L -> R (in COXPD31; uncertain significance; FT dbSNP:rs1057518739)" FT /evidence="ECO:0000269|PubMed:27799064" FT /id="VAR_078013" FT CONFLICT 63..64 FT /note="RG -> AR (in Ref. 1; AAC51231)" FT /evidence="ECO:0000305" FT CONFLICT 200 FT /note="E -> Q (in Ref. 1; AAC51231)" FT /evidence="ECO:0000305" FT CONFLICT 348 FT /note="P -> A (in Ref. 1; AAC51231)" FT /evidence="ECO:0000305" FT CONFLICT 467 FT /note="V -> L (in Ref. 1; AAC51231)" FT /evidence="ECO:0000305" SQ SEQUENCE 713 AA; 80641 MW; 9DBB26B74355B9C1 CRC64; MLCVGRLGGL GARAAALPPR RAGRGSLEAG IRARRVSTSW SPVGAAFNVK PQGSRLDLFG ERRGLFGVPE LSAPEGFHIA QEKALRKTEL LVDRACSTPP GPQTVLIFDE LSDSLCRVAD LADFVKIAHP EPAFREAAEE ACRSIGTMVE KLNTNVDLYQ SLQKLLADKK LVDSLDPETR RVAELFMFDF EISGIHLDKE KRKRAVDLNV KILDLSSTFL MGTNFPNKIE KHLLPEHIRR NFTSAGDHII IDGLHAESPD DLVREAAYKI FLYPNAGQLK CLEELLSSRD LLAKLVGYST FSHRALQGTI AKNPETVMQF LEKLSDKLSE RTLKDFEMIR GMKMKLNPQN SEVMPWDPPY YSGVIRAERY NIEPSLYCPF FSLGACMEGL NILLNRLLGI SLYAEQPAKG EVWSEDVRKL AVVHESEGLL GYIYCDFFQR ADKPHQDCHF TIRGGRLKED GDYQLPVVVL MLNLPRSSRS SPTLLTPSMM ENLFHEMGHA MHSMLGRTRY QHVTGTRCPT DFAEVPSILM EYFANDYRVV NQFARHYQTG QPLPKNMVSR LCESKKVCAA ADMQLQVFYA TLDQIYHGKH PLRNSTTDIL KETQEKFYGL PYVPNTAWQL RFSHLVGYGA RYYSYLMSRA VASMVWKECF LQDPFNRAAG ERYRREMLAH GGGREPMLMV EGMLQKCPSV DDFVSALVSD LDLDFETFLM DSE //